ATER vs. NMHI, MRAI, HKIT, DLPN, APCX, PMEC, SWAG, GMM, VRAR, and AREN
Should you be buying Aterian stock or one of its competitors? The main competitors of Aterian include Nature's Miracle (NMHI), Marpai (MRAI), Hitek Global (HKIT), Dolphin Entertainment (DLPN), AppTech Payments (APCX), Primech (PMEC), Stran & Company, Inc. (SWAG), Global Mofy Metaverse (GMM), The Glimpse Group (VRAR), and The Arena Group (AREN). These companies are all part of the "business services" sector.
Aterian (NASDAQ:ATER) and Nature's Miracle (NASDAQ:NMHI) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, community ranking, valuation, media sentiment, institutional ownership, risk, earnings and dividends.
In the previous week, Nature's Miracle had 2 more articles in the media than Aterian. MarketBeat recorded 2 mentions for Nature's Miracle and 0 mentions for Aterian. Aterian's average media sentiment score of 1.40 beat Nature's Miracle's score of 0.81 indicating that Aterian is being referred to more favorably in the media.
Nature's Miracle has a net margin of 0.00% compared to Aterian's net margin of -42.16%. Nature's Miracle's return on equity of 0.00% beat Aterian's return on equity.
Nature's Miracle has lower revenue, but higher earnings than Aterian.
Aterian has a beta of 1.96, meaning that its share price is 96% more volatile than the S&P 500. Comparatively, Nature's Miracle has a beta of -0.6, meaning that its share price is 160% less volatile than the S&P 500.
Aterian received 22 more outperform votes than Nature's Miracle when rated by MarketBeat users.
7.0% of Aterian shares are owned by institutional investors. Comparatively, 94.6% of Nature's Miracle shares are owned by institutional investors. 4.7% of Aterian shares are owned by insiders. Comparatively, 36.2% of Nature's Miracle shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Summary
Nature's Miracle beats Aterian on 7 of the 12 factors compared between the two stocks.
Get Aterian News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATER and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ATER and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
